Literature DB >> 7987807

Telomere shortening in leukemic cells is related to their genetic alterations but not replicative capability.

K Ohyashiki1, J H Ohyashiki, T Fujimura, K Kawakubo, T Shimamoto, M Saito, S Nakazawa, K Toyama.   

Abstract

We compared telomere length in donor leukemic cells and corresponding established cell lines from three patients with chronic myeloid leukemia (CML) and three with acute lymphoblastic leukemia (ALL) to study the relation between the immortalization capacity of hematologic neoplasms and telomere length. Six of the seven established leukemia cell lines (four CML and two ALL) carried additional chromosome changes and had shorter telomere repeats than those of the donor patients' leukemic cells; the remaining ALL line showed no significant difference in telomere length between fresh leukemic cells and the corresponding cell line. Thus, most established leukemic cells lose effective telomerase activity during the process of establishment, and reduction in telomere length of established leukemic cells appeared to be associated with the presence of additional chromosome changes.

Entities:  

Mesh:

Year:  1994        PMID: 7987807     DOI: 10.1016/0165-4608(94)90047-7

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

1.  Individual telomere lengths in chronic myeloid leukemia.

Authors:  Oumar Samassekou; Aimé Ntwari; Josée Hébert; Ju Yan
Journal:  Neoplasia       Date:  2009-11       Impact factor: 5.715

2.  Establishment and characterization of a new human cell line (EJ) derived from endometrial carcinoma.

Authors:  Keiichi Isaka; Hirotaka Nishi; Toshihide Nakada; Yumi Osakabe; Mitsuyasu Hokamura; Hiromi Serizawa; Yoshiro Ebihara; Masaomi Takayama
Journal:  Hum Cell       Date:  2002-12       Impact factor: 4.174

3.  Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation.

Authors:  C P Schröder; G B Wisman; S de Jong; W T van der Graaf; M H Ruiters; N H Mulder; L F de Leij; A G van der Zee; E G de Vries
Journal:  Br J Cancer       Date:  2001-05-18       Impact factor: 7.640

4.  Increased telomerase activities in human pancreatic duct adenocarcinomas.

Authors:  M Tsutsumi; T Tsujiuchi; O Ishikawa; T Majima; M Yoshimoto; Y Sasaki; T Fukuda; H Oohigashi; Y Konishi
Journal:  Jpn J Cancer Res       Date:  1997-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.